TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive The Meeting Worth Lobbying For: A “PRG” For Disease-Specific Review; NCI Plans Six. June 23, 2000
TCL Archive NCI Faces $32 Million Budget Cut In FY 2006; NIH Tells Grantees To Expect 2.35 Percent Reduction In Award Funds. January 13, 2006
